WORLD LEADERS IN ALZHEIMER RESEARCH AND CARE UNITE FOR FIRST TIME AT WORLD ALZHEIMER CONGRESS 2000

Press Releases »

WORLD LEADERS IN ALZHEIMER RESEARCH AND CARE UNITE FOR FIRST TIME

AT WORLD ALZHEIMER CONGRESS 2000


WHO/WHAT:   World Alzheimer Congress 2000: "With Change in Mind"
The Alzheimer's Association (U.S.A.), Alzheimer's Disease International and the Alzheimer Society of Canada will host World Alzheimer Congress 2000 (Alzheimer 2000).
Over a 10-day span, 5,000 attendees from around the globe will participate in Alzheimer 2000 to share information on pivotal research and creative care. This event will mark the first time that researchers, physicians, and other Alzheimer specialists from around the world will unite to improve the lives of people affected by Alzheimer's disease.
WHY:    By the year 2025, more than 22 million people worldwide will develop Alzheimer's disease.  It's a growing global crisis, in need of a global solution.
WHEN:   World Alzheimer Congress 2000 is segmented into three events:
Alzheimer 2000 Event  Main Audience                 Dates
Pivotal Research      Researchers & Clinicians      July 9-13, 2000
Bridging Research     Physicians                    July 13-14, 2000
and Care
Creative Care         Hands-on care professionals   July 15-18, 2000

ADI members

WHERE:  Washington Hilton and Towers
Washington, D.C., U.S.A.
For more on information about:
-- Submission of abstracts, registration/hotel accommodations, exhibit space, sponsorship, CONTACT the Alzheimer 2000 information line, 312-335-5813 or visit [email protected]
-- Media credentials and press room guidelines,
CONTACT Julie Miller, 312-335-5776 or [email protected],
or Nicolle Heller, 312-335-4037 or [email protected].
SOURCE  Alzheimer's Association
Web site:  http://www.alz.org



ข่าวthe Alzheimer+o:healวันนี้

ADVANCEMENTS IN TREATMENT, DIAGNOSIS AND RISK REDUCTION STRATEGIES HIGHLIGHTED AT ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE

New research reported at the Alzheimer's Association International Conference(R) (AAIC(R)) 2023 covered the breadth of Alzheimer's disease and dementia research, including advancements in treatment, early and accurate diagnosis, and our understanding of risk factors for Alzheimer's and other dementias. AAIC is the premier annual forum for presentation and discussion of the latest Alzheimer's and dementia research. This year's conference took place both virtually and in-person in Amsterdam,

ALZHEIMER'S ASSOCIATION STATEMENT ON DONANEMAB PHASE 3 DATA REPORTED AT AAIC 2023

The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer's disease demonstrate an important advancement in Alzheimer's research and treatment. The full...

HISTORY OF HYPERTENSIVE DISORDERS DURING PREGNANCY LINKED TO INCREASED RISK OF DEMENTIA

Experiences of high blood pressure disorders during pregnancy are associated with an increased risk of vascular dementia and accelerated brain aging, according to studies reported today at the Alzheimer's...

HIGHLIGHTS FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2022

New research reported at the Alzheimer's Association International Conference(R) (AAIC(R) ) 2022 covered the breadth of Alzheimer's and dementia research, including the basic biology of aging and the brain, risk factors and...

LOWER SOCIOECONOMIC STATUS IN CHILDHOOD, PERSISTENT LOW WAGES LINKED TO RISK FOR DEMENTIA AND FASTER MEMORY DECLINE

Socioeconomic deprivation, including neighborhood disadvantages and persistent low wages, are associated with higher dementia risk, lower cognitive performance and faster memory decline...

EXPERIENCES OF RACISM ASSOCIATED WITH POOR MEMORY, INCREASED COGNITIVE DECLINE

Experiences of structural, interpersonal and institutional racism are associated with lower memory scores and worse cognition in midlife and old age, especially among Black individuals, according to studies reported today...

PERSISTENT LOSS OF SMELL DUE TO COVID-19 CLOSELY CONNECTED TO LONG-LASTING COGNITIVE PROBLEMS

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2022 Also, ICU Stay May Double Risk of Dementia in Older Adults New insights into factors that may predict, increase or protect against the impact of...

Highlights From The Alzheimer's Association International Conference 2021

Research presented at the Alzheimer's Association International Conference(R) (AAIC(R) ) 2021 suggests COVID-19 is associated with long-term cognitive dysfunction and acceleration of Alzheimer's disease pathology and symptoms....

COVID-19 Associated With Long-Term Cognitive Dysfunction, Acceleration Of Alzheimer's Symptoms

Much has been learned about SARS-CoV-2, the virus that causes the novel coronavirus, since the beginning of the COVID-19 pandemic. However, questions remain about the long-term impact of the virus on our...

Global Dementia Cases Forecasted To Triple By 2050

—New analysis shows a decrease in prevalence due to education countered by increase due to heart health risk factors Positive trends in global education access are expected to decrease dementia prevalence worldwide by 6.2 million cases by the year...